VentriPoint Diagnostics (FRA:5V7) Growth Rank : 0 (As of May. 26, 2024)

View and export this data going back to 2017. Start your Free Trial

What is VentriPoint Diagnostics Growth Rank?

VentriPoint Diagnostics has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

VentriPoint Diagnostics Growth Rank Related Terms

Thank you for viewing the detailed overview of VentriPoint Diagnostics's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

VentriPoint Diagnostics (FRA:5V7) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » VentriPoint Diagnostics Ltd (FRA:5V7) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

VPTDF:USA VPT:Canada

Address

18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4

Website

https://www.ventripoint.com

VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure, and normal hearts. It sells its products in Canada and internationally.

VentriPoint Diagnostics (FRA:5V7) Headlines

No Headlines